Results 11 to 20 of about 25,365 (244)

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity [PDF]

open access: yesPharmaceuticals, 2021
Euphorbia usambarica is a traditional medicine used for gynecologic, endocrine, and urogenital illnesses in East Africa; however, its constituents and bioactivities have not been investigated.
Yu-Chi Tsai   +9 more
doaj   +2 more sources

Novel Latency Reversal Agents for HIV-1 Cure [PDF]

open access: yesAnnual Review of Medicine, 2018
Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART is not curative owing to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow immune recognition and clearance of this reservoir will be necessary to eradicate ...
Vicente Planelles, Adam Spivak
exaly   +3 more sources

HIV-1 latency reversal agent boosting is not limited by opioid use [PDF]

open access: yesJCI Insight
Opioid use may affect the HIV-1 reservoir and its reversal from latency. We studied 47 virally suppressed people with HIV (PWH) and observed that lower concentration of HIV-1 latency reversal agents (LRAs), used with small molecules that did not reverse ...
Tyler Lilie   +11 more
doaj   +2 more sources

Defining stable reference genes in HIV latency reversal experiments. [PDF]

open access: yesJ Virol, 2021
Latency-reversing agents (LRAs) are ubiquitously used in the “shock-and-kill” HIV cure strategy, and their performance is often evaluated by ex vivo quantification of cell-associated HIV RNA. HIV RNA, measured by quantitative PCR (qPCR), is often normalized to internal reference genes, but the expression of these ...
Ceriani C   +8 more
europepmc   +4 more sources

Latency Reversing Agents and the Road to an HIV Cure

open access: yesPathogens
HIV-1 infection cannot be cured due to the presence of HIV-1 latently infected cells. These cells do not produce the virus, but they can resume virus production at any time in the absence of antiretroviral therapy. Therefore, people living with HIV (PLWH)
Louis Tioka   +3 more
doaj   +4 more sources

Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal. [PDF]

open access: yesPLoS Pathogens
The persistence of HIV-1 in long-lived latent reservoirs during suppressive antiretroviral therapy (ART) remains one of the principal barriers to a functional cure. Blocks to transcriptional elongation play a central role in maintaining the latent state,
William J Cisneros   +11 more
doaj   +2 more sources

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents

open access: yesJournal of Virus Eradication, 2019
Shane D. Falcinelli   +7 more
doaj   +2 more sources

A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency

open access: yesViruses, 2023
We sought to explore the hypothesis that host factors required for HIV-1 replication also play a role in latency reversal. Using a CRISPR gene library of putative HIV dependency factors, we performed a screen to identify genes required for latency ...
Terry L. Hafer   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy